Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
14290 | 779 | 22.7 | 44% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
230 | 3 | P GLYCOPROTEIN//FMO3//TRIMETHYLAMINURIA | 49374 |
1171 | 2 | JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS//JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS//NONMEM | 9352 |
14290 | 1 | JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS//IVIVC//NONLINEAR COMPARTMENTAL MODEL | 779 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS | journal | 403493 | 11% | 12% | 87 |
2 | IVIVC | authKW | 172431 | 3% | 20% | 22 |
3 | NONLINEAR COMPARTMENTAL MODEL | authKW | 117590 | 0% | 100% | 3 |
4 | FRACTIONAL KINETICS | authKW | 109468 | 1% | 31% | 9 |
5 | IN VITRO IN VIVO CORRELATION | authKW | 108129 | 4% | 9% | 32 |
6 | DISPOSITION DECOMPOSITION ANALYSIS | authKW | 88191 | 0% | 75% | 3 |
7 | FINITE DIFFERENCE DECONVOLUTION | authKW | 78393 | 0% | 100% | 2 |
8 | HYSTERESIS MINIMIZATION | authKW | 78393 | 0% | 100% | 2 |
9 | PERMANENCE TIME | authKW | 78393 | 0% | 100% | 2 |
10 | PHYSIOLOGICAL FLOW MODELS | authKW | 78393 | 0% | 100% | 2 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 15932 | 81% | 0% | 634 |
2 | Chemistry, Medicinal | 2113 | 16% | 0% | 124 |
3 | Chemistry, Multidisciplinary | 564 | 20% | 0% | 153 |
4 | Mathematical & Computational Biology | 360 | 4% | 0% | 33 |
5 | Engineering, Biomedical | 157 | 4% | 0% | 32 |
6 | Medical Informatics | 119 | 2% | 0% | 13 |
7 | Biology | 97 | 4% | 0% | 30 |
8 | Computer Science, Interdisciplinary Applications | 17 | 2% | 0% | 15 |
9 | Statistics & Probability | 7 | 1% | 0% | 10 |
10 | Education, Scientific Disciplines | 6 | 1% | 0% | 5 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ANALYT DEV PHYS GARDEN 3 | 39197 | 0% | 100% | 1 |
2 | AREA PHARMACEUT PHARMACEUT TECHNOL | 39197 | 0% | 100% | 1 |
3 | AT NURSEITOVA | 39197 | 0% | 100% | 1 |
4 | BERG KOSICE | 39197 | 0% | 100% | 1 |
5 | BIOEQUIVALENCE CDER OPS OGD DBII 2 | 39197 | 0% | 100% | 1 |
6 | BIOOPHARMACEUT PHARMACOKINET | 39197 | 0% | 100% | 1 |
7 | BIOPHARMACEUT PHARMACEUT CHEM | 39197 | 0% | 100% | 1 |
8 | BIOPHARMACEUT PRODUCT VALUE ENHANCEMENT PHARMACEU | 39197 | 0% | 100% | 1 |
9 | COMPUTAT MATH MATH GEOPHYS SB RAS | 39197 | 0% | 100% | 1 |
10 | MAT SCI SOLIDS DEV EXCELLENCE | 39197 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS | 403493 | 11% | 12% | 87 |
2 | BIOPHARMACEUTICS & DRUG DISPOSITION | 68456 | 7% | 3% | 58 |
3 | JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS | 38351 | 3% | 4% | 24 |
4 | JOURNAL OF PHARMACEUTICAL SCIENCES | 20726 | 10% | 1% | 77 |
5 | EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS | 12316 | 3% | 1% | 22 |
6 | PHARMACEUTICAL RESEARCH | 9025 | 6% | 1% | 43 |
7 | INTERNATIONAL JOURNAL OF PHARMACEUTICS | 5417 | 6% | 0% | 47 |
8 | DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY | 4883 | 3% | 0% | 26 |
9 | DISSOLUTION TECHNOLOGIES | 4770 | 1% | 2% | 5 |
10 | PHARMAZEUTISCHE INDUSTRIE | 3443 | 1% | 1% | 10 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | VENG-PEDERSEN, P , (2001) NONCOMPARTMENTALLY-BASED PHARMACOKINETIC MODELING.ADVANCED DRUG DELIVERY REVIEWS. VOL. 48. ISSUE 2-3. P. 265-300 | 32 | 74% | 34 |
2 | ROUDIER, B , DAVIT, BM , BEYSSAC, E , CARDOT, JM , (2014) IN VITRO- IN VIVO CORRELATION'S DISSOLUTION LIMITS SETTING.PHARMACEUTICAL RESEARCH. VOL. 31. ISSUE 9. P. 2529 -2538 | 18 | 90% | 4 |
3 | VENGPEDERSEN, P , (1989) MEAN TIME PARAMETERS IN PHARMACOKINETICS - DEFINITION, COMPUTATION AND CLINICAL IMPLICATIONS .2..CLINICAL PHARMACOKINETICS. VOL. 17. ISSUE 6. P. 424-440 | 41 | 80% | 57 |
4 | CHENG, HY , GILLESPIE, WR , JUSKO, WJ , (1994) MEAN RESIDENCE TIME CONCEPTS FOR NONLINEAR PHARMACOKINETIC SYSTEMS.BIOPHARMACEUTICS & DRUG DISPOSITION. VOL. 15. ISSUE 8. P. 627-641 | 27 | 93% | 5 |
5 | GONZALEZ-GARCIA, I , MANGAS-SANJUAN, V , MERINO-SANJUAN, M , BERMEJO, M , (2015) IN VITRO-IN VIVO CORRELATIONS: GENERAL CONCEPTS, METHODOLOGIES AND REGULATORY APPLICATIONS.DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY. VOL. 41. ISSUE 12. P. 1935 -1947 | 39 | 34% | 1 |
6 | WEISS, M , (1992) THE RELEVANCE OF RESIDENCE TIME THEORY TO PHARMACOKINETICS.EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. VOL. 43. ISSUE 6. P. 571-579 | 33 | 77% | 14 |
7 | CARDOT, JM , TOMIC, I , (2015) IN VITRO IN VIVO CORRELATION BASIS AND APPLICATION TO SLOW RELEASE INJECTABLE FORMULATION, A REVIEW.FARMACIA. VOL. 63. ISSUE 6. P. 781 -791 | 21 | 55% | 2 |
8 | HUHN, E , LANGGUTH, P , (2013) IN VITRO-IN VIVO CORRELATIONS GENERAL PRINCIPLES AND METHODOLOGIES, REGULATORY ASPECTS AND APPLICATIONS (PART 2).PHARMAZEUTISCHE INDUSTRIE. VOL. 75. ISSUE 2. P. 312-+ | 19 | 66% | 0 |
9 | LANGENBUCHER, F , (2003) HANDLING OF COMPUTATIONAL IN VITRO/IN VIVO CORRELATION PROBLEMS BY MICROSOFT EXCEL: III. CONVOLUTION AND DECONVOLUTION.EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS. VOL. 56. ISSUE 3. P. 429-437 | 15 | 100% | 10 |
10 | COSTELLO, C , ROSSENU, S , VERMEULEN, A , CLETON, A , DUNNE, A , (2011) A TIME SCALING APPROACH TO DEVELOP AN IN VITRO-IN VIVO CORRELATION (IVIVC) MODEL USING A CONVOLUTION-BASED TECHNIQUE.JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS. VOL. 38. ISSUE 5. P. 519-539 | 13 | 87% | 5 |
Classes with closest relation at Level 1 |